Art

J-GLOBAL ID：201802242049067040   Reference number：18A0556890

Selective Androgen Receptor Modulator, YK11, Up-Regulates Osteoblastic Proliferation and Differentiation in MC3T3-E1 Cells

選択的アンドロゲン受容体調節剤であるYK11((17α,20E)-17,20-[(1-メトキシエチリデン)ビス(オキシ)]-3-オキソ-19-ノルプレグナ-4,20-ジエン-21-カルボン酸メチルエステル)はMC3T3-E1細胞において骨芽細胞の増殖および分化をアップレギュレートする

Author (6)： Yatsu Tomofumi (Faculty of Pharmaceutical Sciences, Toho University) ,  Kusakabe Taichi (Faculty of Pharmaceutical Sciences, Toho University) ,  Kato Keisuke (Faculty of Pharmaceutical Sciences, Toho University) ,  Inouye Yoshio (Faculty of Pharmaceutical Sciences, Toho University) ,  Nemoto Kiyomitsu (Faculty of Pharmaceutical Sciences, Toho University) ,  Kanno Yuichiro (Faculty of Pharmaceutical Sciences, Toho University)
Material： Biological and Pharmaceutical Bulletin (Web)
Volume： 41  Issue： 3  Page： 394-398(J-STAGE)  Publication year： 2018 
JST Material Number： U1402A  ISSN： 1347-5215  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： androgen receptor ,...
Semi thesaurus term： cellular signal transduction ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0556890&from=J-GLOBAL&jstjournalNo=U1402A") }}

Author keywords (8)： androgen receptor ,  selective androgen receptor modulator ,  MC3T3-E1 cell ,  osteoblastic differentiation ,  androgen receptor ,  selective androgen receptor modulator ,  MC3T3-E1 cell ,  osteoblastic differentiation

JST classification (1)： Basic research of other drugs acting on metabolism  (GW13060I)

Substance index (2)： Dihydrotestosterone ,  YK-11

Reference (33)：

• 1) Mooradian AD, Morley EJ, Korenman GS. Biological actions of androgens. Endocr. Rev., 8, 1-28 (1987).
• 2) Celotti F, Negri Cesi P. Anabolic steroids: a review of their effects on the muscles, of their possible mechanisms of action and of their use in athletics. J. Steroid Biochem. Mol. Biol., 43, 469-477 (1992).
• 3) van de Wijngaart DJ, Dubbink HJ, van Royen ME, Trapman J, Jenster G. Androgen receptor coregulators: recruitment via the coactivator binding groove. Mol. Cell. Endocrinol., 352, 57-69 (2012).
• 4) Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern. Med., 173, 1465-1466 (2013).
• 5) Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S. Study B. Adverse events associated with testosterone administration. N. Engl. J. Med., 363, 109-122 (2010).

Terms in the title (9)： アンドロゲン受容体 ,  ビス ,  ジエン ,  カルボン酸 ,  メチルエステル ,  MC3T3-E1細胞 ,  骨芽細胞 ,  増殖 ,  分化